Dissemination Report – Norbert Nass

Dissemination Report – Norbert Nass

Share this post

Facebook
Twitter
LinkedIn
WhatsApp

Training in techniques for generating patient-derived immuno-oncology models from squamous cell carcinomas

I am Norbert Nass, investigator at Brandenburg Medical School (MHB), Institute of Pathology in Brandenburg / Havel, Germany. Our major research topic is biomarker development for the prediction of therapy success, mostly for gynecological cancers. In this short-term scientific mission in Daniela Costea´s laboratory in Bergen (Norway), I had the opportunity to get trained in the establishment of organotypic models (3D-OTC) for squamous cell carcinomas of head and neck or vulva and cervix. The learnt techniques will be transferred to our laboratory and will enable us to develop more physiologically relevant models to understand the interaction of tumor cells with the cells of their microenvironment. The established contacts to Daniela´s group and the researchers of the Center for Biomarker Research of Bergen will help us in the establishment of collaborative research projects with the members of the Immuno-Model COST-action and beyond. I really enjoyed the stay and thank the members of the host laboratory and the COST action for this opportunity.

Latest Updates

Conference title: ESMO Immuno-Oncology Congress 2025Conference web-page: https://www.esmo.org/meeting-calendar/esmo-immuno-oncology-congress-2025 Conference venue: Queen Elizabeth II Centre in London, United Kingdom. Conference start and end date: 10/12/2025 to 12/12/2025 Title of the presentation:...
Attending the 3R Länd Conference in Tübingen, Germany, with the support of the YRI IMMUNO-model grant was a valuable opportunity to learn about cutting-edge alternatives to animal testing and their...
In the scope of 1 month long STSM at the Science for life laboratory in Stockholm, Sweden, we combined advanced 3D glioblastoma models and different regions of glioblastoma tissue with...
Title: Engineered immune-competent models of metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma using patient-derived hepatocyte organoids and biomaterials Start and end date: 16/02/2026 to 17/04/2026 I am Ana Margarida...
STSM: Short Term Scientific Mission Visit to a host organization located in a different country than the country of affiliation by a researcher or innovator for specific work to be...
The @immunomodel COST Action workshop MODELS, CHALLENGES AND PROMISES OF ADVANCED THERAPIES FOR CANCER: NK CELLS IN THE CLINIC AND INDUSTRY, organized by @MarValesLab CNB-CSIC, brought together leading international experts...

Join us

How to Participate

The COST Action IMMUNO-model welcomes research-active scientists working in the field.

How to Get Involved

  • Read the Project Description MoU;
  •  Inform the Main Proposer/Chair of your interest (email);
  • Apply to join your Working Groups of interest;
  • You will be informed by the working group leaders as soon as your application has been reviewed;
  • Please note, Management Committee nominations are carried out through the COST National Contact Points.

How to participate in an existing Action?

If you would like to join this COST Action please ensure that you read the guidance notes published on the COST website. You can find full documentation regarding general rules and guidelines for COST Actions at www.cost.eu/participate.

Subscribe to our newsletter